JAMA Surgery : Use of Glucagon-Like Peptide-1 Agonists Among Individuals Undergoing Bariatric Surgery in the US
JAMA Network
00:00
Exploring GLP-1 Initiation After Bariatric Surgery
This chapter explores the utilization of GLP-1 agonists among bariatric surgery patients in the US, revealing that 14% of these patients start the therapy due to inadequate weight loss. It discusses the changing guidelines and predictions for the future use of GLP-1 therapy as new research comes to light.
Transcript
Play full episode
